Shopping Cart
Remove All
Your shopping cart is currently empty
Ragistomig
Copy Product Info
🥰Excellent
Catalog No. T9901A-1539Cas No. 2763222-58-6
Ragistomig is an IgG1 monoclonal antibody targeting TNFRSF9/CD274, comprising a variable region with a κ light chain alongside a λ light chain and an IgG1 heavy chain. Its overall structure forms a dimer made of two identical IgG1 heavy chains.
Ragistomig
Ragistomig
Copy Product Info🥰Excellent
Catalog No. T9901A-1539Cas No. 2763222-58-6
Ragistomig is an IgG1 monoclonal antibody targeting TNFRSF9/CD274, comprising a variable region with a κ light chain alongside a λ light chain and an IgG1 heavy chain. Its overall structure forms a dimer made of two identical IgG1 heavy chains.
Product information is being updated, if you want to purchase, please click the bulk custom button.
Add to Quotation
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Chemical Properties
Storage & Solubility Information
| Description | Ragistomig is an IgG1 monoclonal antibody targeting TNFRSF9/CD274, comprising a variable region with a κ light chain alongside a λ light chain and an IgG1 heavy chain. Its overall structure forms a dimer made of two identical IgG1 heavy chains. |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Cas No. | 2763222-58-6 |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Preview
Related Tags: buy Ragistomig | purchase Ragistomig | Ragistomig cost | order Ragistomig
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.